The Magnitude of the Variation in Glycemia: a New Parameter for Risk Assessment in Acute Coronary Syndrome?;Magnitud de la variación de la glucemia: ¿un nuevo instrumento para la evaluación del riesgo en el síndrome coronario agudo?

Revista Espanola de Cardiologia

Volumn 62, Issue 10, 2009, Pages 1099-1108

  Monteiro, Sílvia ^a,b   Gonçalves, Francisco ^a   Monteiro, Pedro ^a,b   Freitas, Mario ^a,b   Providência, Luis A ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Acute coronary syndrome; Admission glycemia; Magnitude of glycemia variation; Metabolic control; Prognosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; MORTALITY; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; HUMANS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS;

EID: 70349779319     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)72378-4     Document Type: Article

References (27)

1. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
2. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
3. Ishihara M., Kojima S., Sakamato T., Asada Y., Tei C., Kimura K., et al., Japanese Acute Coronary Syndrome Study Investigators. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 150 (2005) 814-820
4. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
5. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., and Cox J.L. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
6. Meier J.J., Deifuss S., Klamann A., Launhardt V., Schmiegel W.H., and Nauck M.A. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care 28 (2005) 2551-2553
7. Straumann E., Kurz D.J., Muntwyler J., Stettler I., Furrer M., Naegeli B., et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 150 (2005) 1000-1006
8. Stranders I., Diamant M., Van Gelder E.R., Spruijt H.J., Twisk J.W., Heine R.J., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
9. Meisinger C., Hörmann A., Heier M., Kuch B., and Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol 113 (2006) 229-235
10. Petursson P., Herlitz J., Caidahl K., Gudbjörnsdottir S., Karlsson T., Perers E., et al. Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 116 (2007) 315-320
11. Monteiro S, Gonçalves F, Monteiro P, Freitas M, Providência L. Glycaemia at admission: the metabolic "echocardiography" in acute coronary syndrome patients. Eur J Cardiovasc Prev Rehabil. 2009 Mar 16. [Epub ahead of print].
12. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernández-Avilés F., et al. Guidelines for the Diagnosis and Treatment of Non-ST-segment Elevation Acute Coronary Syndromes. Eur Heart J 28 (2007) 1598-1660
13. Van de Werf F., Bax J., Betriu A., Blomstrom-Lundquist C., Crea F., Falk V., et al. Management of Acute Myocardial Infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 29 (2008) 2909-2945
14. Suleiman M., Hammerman H., Boulos M., Kapeliovich M.R., Suleiman A., Agmon Y., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111 (2005) 754-760
15. Goyal A., Mahaffey K., Garg J., Nicolau J.C., Hochman J.S., Weaver W.D., et al. Prognostic significance of the change in glucose level in the first 24h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27 (2006) 1289-1297
16. Kosiborod M., Inzucchi S., Krumholz H., Xiao L., Jones P., Fiske S., et al. Glucometrics in patients hospitalized with acute myocardial infarction. Defining the optimal outcomes-based measure of risk. Circulation 117 (2008) 1018-1027
17. Bartnik M., Ryden L., Ferrari R., Malmberg K., Pyorala K., Simoons M., et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on Diabetes and the Heart. Eur Heart J 25 (2004) 1880-1890
18. Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendíc S., Rydén L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144
19. Bartnik M., Malmberg K., Norhammar A., Tenerz A., Ohrvik J., and Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 25 (2005) 1990-1997
20. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Hata T., et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J 27 (2006) 2413-2419
21. Ceriello A. Acute hyperglycaemia: a "new" risk factor during myocardial infarction. Eur Heart J 26 (2005) 328-331
22. Nesto R. Diabetes, hyperglycemia, and the cardiologist: a call to action for optimizing care. Rev Cardiovasc Med 7 Suppl 2 (2006) 1-2
23. Marfella R., Siniscalchi M., Esposito K., Sellitto A., De Fanis U., Romano C., et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26 (2003) 3129-3135
24. Zarich S., and Nesto R. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 115 (2007) e436-e439
25. Timmer J., Ottervanger J., De Boer M., Dambrink J.E., Hoorntje J.C.A., Gosselink A.T.M., et al., The Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 999-1002
26. Van den Berghe G., Wouters P.J., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 345 (2001) 1359-1367
27. Malmberg K.A., Rydén L.E., Wedel H., Birkeland K., Bootsma A., Dickstein K., et al. DIGAMI 2 Investigators: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661